Grants per year
Fingerprint
Dive into the research topics where Kristina Young is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
-
Targeting the tumor stroma to enhance radiation efficacy
Young, K. (PI)
American Society of Clinical Oncology
01/1/15 → …
Project: Research
-
Targeting TGFß to Improve Immunotherapy for Resistant Metastatic Breast Cancer
Young, K. (PI)
01/1/19 → 12/31/20
Project: Research
-
Human-in-the-Loop Informed Deep Learning Rectal Tumor Segmentation on Pre-Treatment MRI
Kong, M., DeSilvio, T., Bao, L., Flannery, B., Parker, B. N., Tang, S., Labbad, M., O’Connor, G., Gupta, A., Steinhagen, E., Purysko, A. S., Hall, W., Liska, D., Marderstein, E. L., Carroll, A., Crittenden, M., Gough, M., Young, K. & Viswanath, S. E., 2024, Medical Imaging 2024: Computer-Aided Diagnosis. Chen, W. & Astley, S. M. (eds.). SPIE, 1292707. (Progress in Biomedical Optics and Imaging - Proceedings of SPIE; vol. 12927).Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › peer-review
-
Tumor resident memory CD8 T cells and concomitant tumor immunity develop independently of CD4 help
Medler, T. R., Kramer, G., Bambina, S., Gunderson, A. J., Alice, A., Blair, T., Zebertavage, L., Duhen, T., Duhen, R., Young, K., Crittenden, M. R. & Gough, M. J., Dec 2023, In: Scientific Reports. 13, 1, 6277.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
646 Neoadjuvant immunotherapy combining maveropepimut-S (MVP-S) with letrozole decreases Ki67 and increases Th1 immune response in hormone receptor positive (HR+) early-stage breast cancer (ESBC)
Stanton, S., Page, D., Young, K. & comments, S. A. A. I., Nov 8 2022Research output: Other contribution
-
Angiotensin receptor blockade and stereotactic body radiation therapy for early stage lung cancer ARB & SBRT for early stage lung cancer
Maloney, L. T., Latour, E., Chen, Y., Rice, D., Grossblatt-Wait, A., Nabavizadeh, N., Thomas, C. R., Young, K. H., Walker, J. M., Holland, J. & Grossberg, A. J., 2022, In: Cancer Biology and Therapy. 23, 1, p. 1-8 8 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Angiotensin receptor blockade and stereotactic body radiation therapy for early stage lung cancer ARB & SBRT for early stage lung cancer.
Maloney, L. T., Latour, E., Chen, Y., Rice, D., Grossblatt-Wait, A., Nabavizadeh, N., Thomas, C. R., Young, K. H., Walker, J. M., Holland, J. & Grossberg, A. J., Dec 31 2022, In: Articles, Abstracts, and Reports.Research output: Contribution to journal › Article